Literature DB >> 25645499

Anticoagulation therapy: Perioperative anticoagulation-are we at 'a bridge too far'?

James D Douketis1.   

Abstract

The perioperative management of patients with atrial fibrillation who require an elective surgical or other invasive procedure is an area of ongoing uncertainty. Accumulating evidence from observational studies suggests that the use of bridging anticoagulation with heparin, although well-intentioned, might not reduce perioperative thromboembolism and can increase bleeding.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25645499     DOI: 10.1038/nrcardio.2015.7

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN: 1759-5002            Impact factor:   32.419


  10 in total

1.  Heart disease and stroke statistics--2012 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Elsayed Z Soliman; Paul D Sorlie; Nona Sotoodehnia; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2011-12-15       Impact factor: 29.690

2.  Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  James D Douketis; Alex C Spyropoulos; Frederick A Spencer; Michael Mayr; Amir K Jaffer; Mark H Eckman; Andrew S Dunn; Regina Kunz
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  2014 focused update of the Canadian Cardiovascular Society Guidelines for the management of atrial fibrillation.

Authors:  Atul Verma; John A Cairns; L Brent Mitchell; Laurent Macle; Ian G Stiell; David Gladstone; Michael Sean McMurtry; Stuart Connolly; Jafna L Cox; Paul Dorian; Noah Ivers; Kori Leblanc; Stanley Nattel; Jeff S Healey
Journal:  Can J Cardiol       Date:  2014-08-13       Impact factor: 5.223

4.  Pacemaker or defibrillator surgery without interruption of anticoagulation.

Authors:  David H Birnie; Jeff S Healey; George A Wells; Atul Verma; Anthony S Tang; Andrew D Krahn; Christopher S Simpson; Felix Ayala-Paredes; Benoit Coutu; Tiago L L Leiria; Vidal Essebag
Journal:  N Engl J Med       Date:  2013-05-09       Impact factor: 91.245

5.  Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial.

Authors:  Jeff S Healey; John Eikelboom; James Douketis; Lars Wallentin; Jonas Oldgren; Sean Yang; Ellison Themeles; Hein Heidbuchel; Hein Heidbuchle; Alvaro Avezum; Paul Reilly; Stuart J Connolly; Salim Yusuf; Michael Ezekowitz
Journal:  Circulation       Date:  2012-06-14       Impact factor: 29.690

6.  Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure. Substudy of the RE-LY trial.

Authors:  James D Douketis; Jeff S Healey; Martina Brueckmann; John W Eikelboom; Michael D Ezekowitz; Mandy Fraessdorf; Herbert Noack; Jonas Oldgren; Paul Reilly; Alex C Spyropoulos; Lars Wallentin; Stuart J Connolly
Journal:  Thromb Haemost       Date:  2014-12-04       Impact factor: 5.249

Review 7.  Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates.

Authors:  Deborah Siegal; Jovana Yudin; Scott Kaatz; James D Douketis; Wendy Lim; Alex C Spyropoulos
Journal:  Circulation       Date:  2012-08-21       Impact factor: 29.690

8.  Risks and benefits of anticoagulation in atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.

Authors:  Michael W Cullen; Sunghee Kim; Jonathan P Piccini; Jack E Ansell; Greg C Fonarow; Elaine M Hylek; Daniel E Singer; Kenneth W Mahaffey; Peter R Kowey; Laine Thomas; Alan S Go; Renato D Lopes; Paul Chang; Eric D Peterson; Bernard J Gersh
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2013-06-11

Review 9.  Oral IIa and Xa inhibitors for prevention of stroke in atrial fibrillation: clinical studies and regulatory considerations.

Authors:  Spyridon Deftereos; Dimitrios Tsounis; Georgios Giannopoulos; Charalampos Kossyvakis; Vasiliki Panagopoulou; Konstantinos Raisakis; Christodoulos Stefanadis
Journal:  Curr Clin Pharmacol       Date:  2012-08

10.  Use and outcomes associated with bridging during anticoagulation interruptions in patients with atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).

Authors:  Benjamin A Steinberg; Eric D Peterson; Sunghee Kim; Laine Thomas; Bernard J Gersh; Gregg C Fonarow; Peter R Kowey; Kenneth W Mahaffey; Matthew W Sherwood; Paul Chang; Jonathan P Piccini; Jack Ansell
Journal:  Circulation       Date:  2014-12-12       Impact factor: 29.690

  10 in total
  1 in total

1.  Low molecular weight heparin in surgical valve procedures: When and how much for an optimal prophylaxis?

Authors:  Katarzyna Czerwińska-Jelonkiewicz; Marek Cisowski; Andrzej Bochenek; Piotr Buszman; Krzysztof Milewski; Piotr Kunik; Magdalena Mularska; Krzysztof Kocot; Piotr Politowski; Jakub Brączkowski; Agata Trznadel; Michael S Aboodi; Paweł Buszman
Journal:  Cardiol J       Date:  2018-11-28       Impact factor: 2.737

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.